{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/49172388"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "significant use of capital pertains to salaries and benefits for our employees and external development expenses, such as manufacturing and clinical trial activity, related to our ZFP Therapeutic programs." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sec.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/64319482"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/49172388"] } } }
